Previous Midlife Oestradiol Treatment Results in Long-Term Maintenance of Hippocampal Oestrogen Receptor α Levels in Ovariectomised Rats: Mechanisms and Implications for Memory.
Ovariectomised rats that have received previous administration of oestradiol in midlife display enhanced cognition and increased hippocampal levels of oestrogen receptor (ER)α months after oestradiol treatment ended compared to ovariectomised controls. The present study aimed to investigate the mechanisms by which ERα levels are maintained following midlife oestradiol exposure and the role of ERα in memory in ageing females in the absence of circulating oestrogens. Unliganded ERα has increased interaction with the ubiquitin ligase, C-terminus of Hsc-70 interacting protein (CHIP), leading to increased degradation of the receptor. In our first experiment, we tested the hypothesis that midlife oestradiol exposure in ovariectomised rats results in decreased interaction between CHIP and hippocampal ERα, leading to increased levels of ERα. Middle-aged rats were ovariectomised and received oestradiol or vehicle implants. After 40 days, implants were removed. One month later, rats were killed and hippocampi were processed for whole protein western blotting and co-immunoprecipitation, in which ERα was immunoprecipitated from lysate. As expected, ERα protein expression was increased in rats previously treated with oestradiol compared to vehicle-treated rats. In rats treated with oestradiol, there was a decrease in CHIP-ERα interaction, suggesting that previous oestradiol treatment reduces interaction, slowing the degradation of ERα. In a second experiment, we determined the impact on memory of antagonism of ER in the absence of circulating oestrogens. Rats were ovariectomised and implanted with oestradiol capsules. Capsules were removed after 40 days. Rats received chronic i.c.v. infusion of ER antagonist, ICI 182 780, or artificial cerebrospinal fluid vehicle and were tested on a spatial memory radial-maze task. Rats treated with ICI 182 780 had significantly worse performance (more errors). These experiments provide evidence that previous midlife oestradiol treatment maintains hippocampal ERα by decreasing its interaction with CHIP and that activation of these receptors provides cognitive benefits in the absence of circulating oestrogens.
Program in Neuroscience, Tulane University, New Orleans, LA, USA.|Brain Institute, Tulane University, New Orleans, LA, USA.
K L
KL
Black
Program in Neuroscience, Tulane University, New Orleans, LA, USA.
C F
CF
Witty
Program in Neuroscience, Tulane University, New Orleans, LA, USA. jmdaniel@tulane.edu.|Brain Institute, Tulane University, New Orleans, LA, USA. jmdaniel@tulane.edu.|Department of Psychology, Tulane University, New Orleans, LA, USA. jmdaniel@tulane.edu.
J M
JM
Daniel
D000375:Aging; D000818:Animals; D004958:Estradiol / Q000008:administration & dosage / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000378:metabolism*; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D008568:Memory / Q000502:physiology*; D010052:Ovariectomy; D020318:Rats, Long-Evans; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism
D047628:Estrogen Receptor alpha; D004958:Estradiol; C540442:Stub1 protein, rat; D044767:Ubiquitin-Protein Ligases
degradation; hippocampus; memory; oestradiol; oestrogen receptor